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Abstract. Sarcomas are soft tissue tumors arising from primitive mesenchyme. Small incidence (4-5/100 000 in Europe) is 
the reason their pathogenesis is relatively unknown. Patient (38) complained of a growth on the upper part of right thigh, 
the size of a child’s head. A magnetic resonance imaging (MRI) scan was done and tumefaction was described: oval shape, 
13.5 x 7.5 x 11cm in diameter, without infiltration of surrounding tissue. The tumor was surgically removed and was 
pathohistologically verified as low grade liposarcoma myxoides. After initial presentation the patient presented a series of 
recurrences and metastases in the abdominal wall, extremities and  liver. Soft tissue metastasis from the lower extremities to 
the liver occur in 0.5% of cases and they are usually small and multiple, as in the presented patient. The European Sarcoma 
Medical Oncologist’s guide recommends that every  extremity tumor larger than 5cm and suspicious of malignancy should 
be evaluated using biopsy and imaging methods. A biopsy should be done before excision under ultrasound or computerized 
tomography (CT) guidance with the goal of planning the best therapy protocol and prevention of a generalized disease with 
metastases. The recommended imaging method is an MRI scan, although sarcomas can have a benign presentation.  
Standard therapy includes surgical resection with local radiotherapy.  Liposarcoma myxoides, a rare soft tissue tumor, 
demands biopsy and complete surgical removal with detailed and continuous postoperative imaging follow-up and 
oncological therapy. The therapeutic goal is to increase survival and preserve extremity function. 
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Introduction 

 
Adult soft tissue sarcomas are malignant tumors which 
develop from primitive mesenchyme. Their incidence is 
small (around 4-5/100000 cases per year in Europe) [1] 
which is the main reason their pathogenesis and metas-
tasizing pattern is relatively unknown, and that is also 
the reason why we have few large randomized prospec-
tive studies on this topic. Therefore, scientific papers in 
the form of case presentations are a valuable source of 
information in the ongoing research of this disease.  
Case Presentation 
The patient (38 years old) complained to his general 
practice doctor in July 2013 of a large growth the size of 
a child’s head on the inner side of his right thigh. After 
a physical exam and laboratory analysis of blood and 
urine, a magnetic resonance imaging (MRI) scan of the 
lower extremities was done, which described a tume-
faction beneath the pubic bone and between the obtura-
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tor muscles: clear margins, oval shape, and 13.5 x 7.5 x 
11cm, without infiltration of surrounding tissue, benign 
in appearance. After one month the tumor was surgi-
cally removed. The tumor was pathohistologically veri-
fied as a primary mesenchyme tumor type low grade 
myxoid liposarcoma. Tumor immunophenotipisation: 
CD34-, p53-, Cyclin D1+, rear individual cells <1%, 
Ki-67+ diffuse heterogeneous weak to intensive im-
munopositivity in around 15% of tumor cells. He was 
referred to a multidisciplinary team in September 2013 
which indicated a follow up every two months with 
regular MRI scans. After ten months, a recurrence was 
diagnosed, when a reoperation was done as well as re-
gional lymph node dissection. After that, the multidisci-
plinary team indicated postoperative local radiotherapy 
(RT) which was not conducted due to technical reasons. 
In the meantime, the patient was diagnosed with a tumor 
in the abdominal wall. He was operated on for the third 
time in July 2014 where the abdominal wall tumor was 
removed and the pathohistological finding was the same 
as before (low grade liposarcoma myxoides). The mul-
tidisciplinary team requested a postoperative computer-
ized tomography (CT) scan of the thorax and abdomen. 
A suspicious lesion was then noticed in the liver as well 
as a group of enlarged lymph nodes in the mediastinum. 
MRI of the right thigh did not show any sign of recur-
rence. A positron emission tomography (PET) scan was 
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done which showed a nodular tumefaction in the neck 
on the left posterior side in the subcutaneous tissue 
12mm in diameter as well as a circular defect in the 
medial part of hind knee area in the subcutaneous tissue. 
The multidisciplinary team indicated systemic chemo-
therapy in three cycles using monotherapy with Doxo-
rubicin. Because of a new tumefaction in the left elbow 
and a recurrence in the primary surgical site, the chem-
otherapy was continued for three more cycles, but was 
aborted due to cardiotoxity. The above-mentioned re-
currence was surgically removed in September 2015. 
RT was again not applied. This was followed by recur-
rence in January 2016.  CT scan of the thorax, abdomen 
and pelvis was done confirming lesion in the second 
segment of liver (5.7cm) (Fig. 1) as well as in the right 
inguinal area.  
Five months after that, ultrasound of the abdomen 
showed enlargement of the solitary soft tissue lesion in 
the left lobe of the liver (9.8 x 9.2 cm). The patient was 
referred to our clinic  for further treatment of the liver 
lesion in July 2016. After adequate preoperative prepa-
ration, „J” laparotomy was performed (with continuous 
ischemia using the Pringle maneuver), finding a large 
solid tumefaction in the left lobe of the liver 10x8 cm in 
size. The tumor was verified as a myxoid liposarcoma 
metastasis. In the follow up course the patient was diag-
nosed with multiple liver and lung metastases which 
were verified with CT scans. Table 1 is showing all the 
therapeutic and diagnostic procedures performed in the 
patient in chronological order. 
Discussion  
Liposarcoma is the second most common soft tissue 
sarcoma. The exact cause of their occurence is 
unknown. Patients usualy first notice a growth on the 
extremity after an injury. However it is certain that 
liposarcomas do not occur  because of trauma. They 
most often occur between 30 and 50 years of age with a 
mild male predominance. They can occur anywhere in 
the body where fat tissue is present, most commonly in 
the deep fat tissue of the extremity (59%), abdomen and 
thorax (19%), retroperitoneum (15%), head and neck 
(9%) [2]. The greatest survival rate is with liposarcoma 
of the extremities and the least with retroperitoneal 
sarcomas. The local recurrence rate is arround 78% [3].  
According to the histology type, liposarcomas can 
be classified as: dedifferentiated, myxoid and 
pleomorphic [4]. Myxoid liposarcoma is the most 
common subtype and it is more frequent in younger 
people. It is different from other liposarcomas in its 
unusual pattern of metastasis in tissues such as: bones 
(most common), retro-peritoneum, extremities and the 
axillary region, while other localities are affected only 
in advanced stages of the disease [5,6].  
All other liposarcomas usually present with metasta-
ses primarily in the lungs. Soft tissue sarcoma metasta-
ses of the lower extremities occur in the liver in around 
0.5% of cases [7] and usually present as small multiple 
metastases and rarely as big solitary tumors such as the 
one in the patient described in this presentation. 
 
Fig. 1 Transverse abdominal CT scan. Large metastasis 
is visible in second segment (black arrow) 
Table 1 Overview of the diagnostic and therapy 
procedures. 
Disease events Time 
period 
Operation- excision of the growth in the 
right thigh (PH: low grade myxoid 
liposarcoma) 
August 
2013 
Operation- excision of the recurrent growth 
on the right thigh with dissection of the 
regional lymph nodes (PH: low grade 
myxoid liposarcoma) 
May 2014 
Radiotherapy indicated- not executed   
Operation- excision of the growth in the 
abdominal wall (PH: liposarcoma 
myxoides) 
July 2014 
CT of the thorax and abdomen confirms 
presence of enlarged lymph nodes in the 
mediastinum and a focal lesion on the liver 
August 
2014 
PET/CT reveals tumor lesions in the neck 
hind knee area 
September 
2014 
Local recurrence in the right thigh and left 
elbow 
September 
2014 
Chemotherapy is conducted but cancelled 
after five cycles because of cardio toxicity  
October 
2014 
Operation- excision of the local recurrence 
on the right thigh 
September 
2015 
Radiotherapy indicated- not executed September 
2015 
Operation- excision of the local recurrence 
on the right thigh 
December 
2015 
Local recurrence on the right thigh January 
2016 
Enlargement of the liver focal lesion  May 2016 
Operation- excision of the liver metastasis July 2016 
Multiple metastasis in the lung and liver  February 
2017 
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According to the European society of medical on-
cologists (ESMO), every patient with a tumor suspi-
cious for soft tissue sarcoma of the extremity should be 
referred to a specialized diagnostic center for a three-
way evaluation: biopsy, physical exam and imaging [8]. 
The recommended imaging method for evaluation is 
MRI, which was used for diagnosing the presented pa-
tient as well. However, initially the tumefaction was 
described as a benign tumor lesion with clear margins 
and no infiltration of surrounding tissue. As shown by 
Francois et al. myxoid liposarcomas, although malig-
nant tumors, can deceive with their benign appearance 
[9]. For this reason, any growth which is larger than 
5cm and deeply seated in the tissue should be suspicious 
for malignancy. An important diagnostic tool which is 
also used for planning further therapy is a tumor biopsy 
which should be done before tumor excision. The first 
biopsy is performed under ultrasound or CT guidance 
and in case of failure, a surgical biopsy is needed. The 
histological classification should be made according to 
the World Health Organization classification from 2013. 
The grade of the malignancy should always be deter-
mined if possible, because it has prognostic value. The 
grade is determined based on degree of necrosis, differ-
entiation of the tumor and mitosis count [10].  
As far as other diagnostic modalities are concerned, 
the ESMO guide recommends CT of the thorax, for 
patients who were diagnosed with soft tissue sarcoma 
by biopsy, in order to rule out pulmonary metastases 
before definitive treatment. CT of the abdomen and 
pelvis do not have to be done routinely, but they are 
recommended in certain histological types, including 
myxoid liposarcomas. Early diagnostics could lead to 
earlier discovery of metastatic disease, and an earlier 
introduction of systemic chemotherapy.  
Wide excision with negative margins in combination 
with postoperative radiotherapy is the standard in treating 
tumors of the trunk and extremity because that provides a 
high degree of local control with preservation of extremity 
function. The margin of surgical excision depends on 
multiple factors: histological subtype of the tumor, 
application of preoperative chemo or/and radiotherapy and 
presence of anatomical barriers (fascia, periost etc.). In 
some cases amputation of the extremity should be 
considered. Although radiation therapy is reserved mostly 
for patients with high grade tumors, it can be justified in 
low grade tumors which are deeply seated in the tissue and 
larger than 5cm. This decision should be made by a 
multidisciplinary team taking in consideration the 
anatomical localization of the tumor, as well as the 
risk/benefit ratio in radiating patients with a low grade 
tumor. Local radiation therapy reduces the incidence of 
local recurrence which is often related to metastatic 
disease. The presented patient did not receive any local 
radiation therapy due to technical reasons, which may have 
led to multiple recurrences and the generalized metastatic 
disease. However, since this is a case presentation and this 
is only one case, it is difficult to draw conclusions and 
determine correlation between the absence of radiotherapy 
and advancement of the disease.  
Neoadjuvant radiotherapy is not recommended as a 
routine method, but it can be used in radiosensitive 
subtypes such as myxoid liposarcomas in order to shrink 
the tumor preoperatively. The main drawbacks of this 
method are postoperative surgical complications which 
occur at the site of tumor excision.  
The role of adjuvant chemotherapy has not been 
confirmed, therefore it is also not recommended as a 
routine method. It can however be used in patients 
whose tumor is near an anatomical structure which 
could be damaged using radiotherapy or in certain 
chemo-sensitive tumors.  
Advanced disease with extrapulmonary metastases is 
best treated with systemic chemotherapy. In certain 
patients, metastases can be treated surgically, depending 
on the localization of the tumor and progression of the 
disease. Standard chemotherapy used today is Doxoru-
bicin as a monotherapy, since it has not been formally 
proven that polytherapy is superior to monotherapy. On 
the other hand, some studies are in favor of polytherapy 
in certain chemo-sensitive types of tumors [11]. The 
most dangerous side effect of  Doxorubicin is cardio 
toxicity, which was observed in the presented patient.  
As far as follow up is concerned, the ESMO guide 
recommends that all patients with low grade tumors 
should be controlled every four to six months in the first 
three to five years and then once a year. Standard con-
trol should encompass a physical exam (and MRI scan 
if needed), as well as a chest X ray to rule out pulmo-
nary metastases.   
Regarding prognosis in these patients, negative 
prognostic factors are: age (>45 years) [12], size of the 
tumor (>10 cm) [13], percentage of differentiation of cells 
(>5%)[14] and tumor necrosis [12]. All of these factors 
were present in the presented patient except his age.  
Conclusion 
Liposarcomas rarely metastasize from the extremity to 
the liver. When they do, it is usually in the form of mul-
tiple metastases, and rarely as large solitary tumefac-
tions, which is a sign of an advanced stage of the dis-
ease. According to the ESMO guide, if there is suspi-
cion of a soft tissue sarcoma,  it is necessary to do an 
ultrasound or CT guided biopsy before excision in order 
to plan a therapeutic protocol based on the pathohisto-
logical diagnosis. In order to prevent recurrence, it is 
necessary to consider local radiotherapy after surgical 
excision in tumors that are primary, deeply seated and 
larger than 5cm even though they are low grade. Also, it 
is recommended to do a CT or a chest X-ray of the 
thorax and in subtypes such as liposarcoma myxoides a 
CT of the abdomen and pelvis as well, in order to rule 
out the presence of metastases. Systemic chemotherapy 
is the method of choice in treating advanced disease 
with extra-pulmonary metastases and in certain cases, 
surgical therapy can be performed. Follow up in low 
grade tumors should be done every six months in the 
first two to three years with a thorough physical exam 
and a chest X-ray. 
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